Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transurethral prostatectomy.

W K Mebust1

  • 1Section of Urology, University of Kansas Medical Center, Kansas City.

The Urologic Clinics of North America
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Transurethral prostatectomy for benign prostatic hyperplasia (BPH) shows excellent immediate results. However, insurance data suggest higher long-term mortality and reoperation rates than previously reported, warranting further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transurethral prostatectomy: immediate and postoperative complications. a cooperative study of 13 participating institutions evaluating 3,885 patients. 1989.

The Journal of urology·2002
Same author

Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol, 141: 243-247, 1989.

The Journal of urology·2001
Same author

Muscarinic cholinergic receptors promote growth of human prostate cancer cells.

The Prostate·1997
Same author

Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association.

Medical care·1995
Same author

Symptoms and urodynamics.

The Journal of urology·1995
Same author

Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients.

Endocrinology·1994
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Area of Science:

  • Urology
  • Surgical Procedures
  • Health Outcomes

Background:

  • Transurethral prostatectomy is a prevalent surgical procedure for benign prostatic hyperplasia (BPH).
  • Over 90% of BPH surgeries in the US are performed transurethrally.
  • The procedure is known for its low mortality and excellent immediate postoperative outcomes.

Purpose of the Study:

  • To evaluate the long-term outcomes of transurethral prostatectomy.
  • To compare chart review data with insurance claims data regarding patient outcomes.
  • To identify potential discrepancies in reported long-term mortality and reoperation rates.

Main Methods:

  • Review of existing chart data for long-term patient outcomes.
  • Analysis of insurance claims data to assess mortality and reoperation rates.

Related Experiment Videos

  • Comparison of findings from chart reviews versus insurance claims.

    • Main Results:

    • Chart review data indicate satisfactory long-term results following transurethral prostatectomy.
    • Insurance claims data suggest higher later mortality and reoperation rates than previously reported.
    • A discrepancy exists between different data sources regarding the long-term efficacy and safety of the procedure.

    Conclusions:

    • While immediate outcomes are excellent, long-term results of transurethral prostatectomy require further evaluation.
    • Insurance claims data raise concerns about the long-term safety and effectiveness of the procedure.
    • Randomized controlled trials are needed to definitively assess the long-term outcomes of transurethral prostatectomy for BPH.